Minerva Neurosciences Inc (NERV)
Drugs • Health Care
Percentage
Change
| Mar 15 | Mar 16 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 23 | Feb 24 | Feb 25 | Mar 26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income to Common | -21 | -293 | ||||||||||
Net Income | -21 | -293 | ||||||||||
Profit | -21 | -14 | ||||||||||
Net Income Continuing | -21 | -14 | ||||||||||
Pretax Income | -21 | -14 | ||||||||||
Total Non-operating Income | 1 | 1 | ||||||||||
Operating Income | -22 | -15 | ||||||||||
Total Costs and Expenses | -22 | -15 | ||||||||||
Operating Expenses | -22 | -15 | ||||||||||
Research and Development Expenses | -12 | -6 | ||||||||||
Selling, General & Administrative Expenses | -10 | -9 |